We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

28 hedge funds and large institutions have $186M invested in Cogent Biosciences in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22.23% more ownership

Funds ownership: 0% → 22.23% (+22%)

Holders
28
Holders Change
+28
Holders Change %
–
% of All Funds
0.64%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.09%
New
28
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AVAI
Atlas Venture Associates IX
Massachusetts
+$37.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$26.8M
3
Fidelity International
Fidelity International
Bermuda
+$12.6M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$12M
5
Jennison Associates
Jennison Associates
New York
+$9.96M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AVAI
1
Atlas Venture Associates IX
Massachusetts
$37.3M +$37.3M +840,384 New
NHAS
2
Novo Holdings A/S
Denmark
$31.7M +$7.39M +166,295 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$29M +$26.8M +603,148 New
Fidelity International
4
Fidelity International
Bermuda
$13.7M +$12.6M +284,569 New
SAM
5
Sectoral Asset Management
Quebec, Canada
$12M +$12M +270,386 New
Jennison Associates
6
Jennison Associates
New York
$9.78M +$9.96M +224,189 New
SM
7
Sabby Management
Florida
$9.38M +$9.38M +210,963 New
Wellington Management Group
8
Wellington Management Group
Massachusetts
$9.22M +$9.23M +207,591 New
NLVP
9
New Leaf Venture Partners
New York
$6.11M +$6.11M +137,500 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$4.16M +$4.16M +93,525 New
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$3.6M +$3.6M +80,975 New
WA
12
Wasatch Advisors
Utah
$2.82M +$2.82M +63,525 New
Victory Capital Management
13
Victory Capital Management
Texas
$2.78M +$2.78M +62,500 New
PIM
14
Platinum Investment Management
Australia
$2.5M +$2.5M +56,250 New
Morgan Stanley
15
Morgan Stanley
New York
$2.37M +$2.37M +53,243 New
MIM
16
Monashee Investment Management
Massachusetts
$1.94M +$1.94M +43,750 New
HI
17
HBK Investments
Texas
$1.78M +$1.78M +40,000 New
Norges Bank
18
Norges Bank
Norway
$1.11M +$1.11M +25,000 New
Millennium Management
19
Millennium Management
New York
$982K +$982K +22,101 New
SSA
20
Schonfeld Strategic Advisors
New York
$811K +$811K +18,250 New
HCMT
21
Highland Capital Management (Texas)
Texas
$770K +$770K +17,336 New
Goldman Sachs
22
Goldman Sachs
New York
$598K +$598K +13,449 New
Citadel Advisors
23
Citadel Advisors
Florida
$416K +$416K +9,350 New
DIM
24
DC Investments Management
Virginia
$395K +$395K +8,881 New
AC
25
Athanor Capital
New York
$248K +$248K +5,575 New
1
2

COGT Hedge Fund Activity: Q1 2018 in Review

28 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q1 2018, worth a combined $186M.

Buyers outnumbered sellers: 28 funds opened new COGT positions and 0 closed out — a net gain of 28 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Atlas Venture Associates IX, opening a new position worth an estimated $37.3M.

  • 28 institutional investors held Cogent Biosciences (COGT) as of Q1 2018, up from 0 in Q4 2017.
  • Funds reported $186M of Cogent Biosciences stock for Q1 2018.
  • 28 funds opened new Cogent Biosciences positions in Q1 2018 and 0 closed out, a net change of +28 holders.
  • The largest Cogent Biosciences buyer in Q1 2018 was Atlas Venture Associates IX, an estimated $37.3M added.

Based on aggregated 13F filings for Q1 2018.